CVE-2024-29129

MEDIUMCVSS 6.1/10EPSS 0.37%

Last modified

CVE-2024-29129 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.. EPSS estimates a 0.37% chance of exploitation in the next 30 days.

Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.

Metrics

CVSS 3.1
6.1/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

EPSS Probability
0.37%

29.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
OxyextrasOxyextras< 1.4.5

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2024-29129?
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in WPLIT Pty Ltd OxyExtras allows Reflected XSS.This issue affects OxyExtras: from n/a through 1.4.4.
How severe is CVE-2024-29129?
CVE-2024-29129 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.37% probability of exploitation in the next 30 days.
How do I fix CVE-2024-29129?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2024-29129?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST